Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNONW) Consolidated Net Income (2021 - 2025)

Historic Consolidated Net Income for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to -$3.4 million.

  • Tenon Medical's Consolidated Net Income fell 550.54% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year increase of 497.64%. This contributed to the annual value of -$13.8 million for FY2024, which is 1236.98% up from last year.
  • As of Q3 2025, Tenon Medical's Consolidated Net Income stood at -$3.4 million, which was down 550.54% from -$2.9 million recorded in Q2 2025.
  • Tenon Medical's Consolidated Net Income's 5-year high stood at -$200000.0 during Q1 2021, with a 5-year trough of -$7.9 million in Q4 2022.
  • Over the past 5 years, Tenon Medical's median Consolidated Net Income value was -$3.3 million (recorded in 2022), while the average stood at -$3.5 million.
  • As far as peak fluctuations go, Tenon Medical's Consolidated Net Income tumbled by 107650.0% in 2022, and later surged by 6012.63% in 2023.
  • Over the past 5 years, Tenon Medical's Consolidated Net Income (Quarter) stood at -$2.8 million in 2021, then plummeted by 178.58% to -$7.9 million in 2022, then skyrocketed by 60.13% to -$3.2 million in 2023, then fell by 0.47% to -$3.2 million in 2024, then fell by 6.9% to -$3.4 million in 2025.
  • Its Consolidated Net Income was -$3.4 million in Q3 2025, compared to -$2.9 million in Q2 2025 and -$3.7 million in Q1 2025.